Promacta Powder, For Suspension
Product Images NDC 0078-0697
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Promacta (NDC 0078-0697). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Promacta-ifu-illustrations-1 (Promacta Spl Graphic 02)
Promacta-ifu-illustrations-2 (Promacta Spl Graphic 03)
Promacta-ifu-illustrations-3 (Promacta Spl Graphic 04)
Promacta-ifu-illustrations-4 (Promacta Spl Graphic 05)
Promacta-ifu-illustrations-5 (Promacta Spl Graphic 06)
Promacta-ifu-illustrations-6 (Promacta Spl Graphic 07)
Promacta-ifu-illustrations-7 (Promacta Spl Graphic 08)
Promacta-ifu-illustrations-8 (Promacta Spl Graphic 09)
Promacta-ifu-illustrations-9 (Promacta Spl Graphic 10)
Promacta-ifu-illustrations-10 (Promacta Spl Graphic 11)
Promacta For Oral Suspension 12.5 mg 30 Packets Outer Carton (Promacta Spl Graphic 12)
Promacta 25mg 30 Count Label (Promacta Spl Graphic 13)
Promacta 50mg 30 Count Label (Promacta Spl Graphic 14)
Promacta 75mg 30 Count Label (Promacta Spl Graphic 15)
Promacta 12.5mg 30 Count Label (Promacta Spl Graphic 16)
Promacta For Oral Suspension 12.5 mg 30 Packets Outer Carton (Promacta Spl Graphic 17)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.